Axsome Return On Assets from 2010 to 2024
AXSM Stock | USD 79.04 0.13 0.16% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (0.41) | Current Value (0.43) | Quarterly Volatility 0.65085933 |
Check Axsome Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Axsome main balance sheet or income statement drivers, such as Interest Expense of 6.8 M, Selling General Administrative of 339.3 M or Other Operating Expenses of 476.2 M, as well as many exotic indicators such as Price To Sales Ratio of 12.69, Dividend Yield of 0.0112 or Operating Cycle of 481. Axsome financial statements analysis is a perfect complement when working with Axsome Therapeutics Valuation or Volatility modules.
Axsome | Return On Assets |
Latest Axsome Therapeutics' Return On Assets Growth Pattern
Below is the plot of the Return On Assets of Axsome Therapeutics over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Axsome Therapeutics' Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Axsome Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Return On Assets | 10 Years Trend |
|
Return On Assets |
Timeline |
Axsome Return On Assets Regression Statistics
Arithmetic Mean | (0.80) | |
Geometric Mean | 0.70 | |
Coefficient Of Variation | (81.65) | |
Mean Deviation | 0.47 | |
Median | (0.71) | |
Standard Deviation | 0.65 | |
Sample Variance | 0.42 | |
Range | 2.5524 | |
R-Value | 0.47 | |
Mean Square Error | 0.36 | |
R-Squared | 0.22 | |
Significance | 0.08 | |
Slope | 0.07 | |
Total Sum of Squares | 5.93 |
Axsome Return On Assets History
About Axsome Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Axsome Therapeutics income statement, its balance sheet, and the statement of cash flows. Axsome Therapeutics investors use historical funamental indicators, such as Axsome Therapeutics's Return On Assets, to determine how well the company is positioned to perform in the future. Although Axsome Therapeutics investors may use each financial statement separately, they are all related. The changes in Axsome Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Axsome Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Axsome Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Axsome Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2024 | ||
Return On Assets | (0.41) | (0.43) |
Pair Trading with Axsome Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axsome Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Axsome Stock
0.72 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
0.66 | YS | YS Biopharma Report 22nd of April 2024 | PairCorr |
0.66 | DNLI | Denali Therapeutics Financial Report 13th of May 2024 | PairCorr |
0.59 | MESO | Mesoblast Trending | PairCorr |
0.56 | TCRX | Tscan Therapeutics Financial Report 8th of May 2024 | PairCorr |
The ability to find closely correlated positions to Axsome Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axsome Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axsome Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axsome Therapeutics to buy it.
The correlation of Axsome Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axsome Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axsome Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axsome Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Axsome Therapeutics Correlation against competitors. To learn how to invest in Axsome Stock, please use our How to Invest in Axsome Therapeutics guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for Axsome Stock analysis
When running Axsome Therapeutics' price analysis, check to measure Axsome Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axsome Therapeutics is operating at the current time. Most of Axsome Therapeutics' value examination focuses on studying past and present price action to predict the probability of Axsome Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axsome Therapeutics' price. Additionally, you may evaluate how the addition of Axsome Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Axsome Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axsome Therapeutics. If investors know Axsome will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axsome Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.27) | Revenue Per Share 5.957 | Quarterly Revenue Growth 1.935 | Return On Assets (0.25) | Return On Equity (1.59) |
The market value of Axsome Therapeutics is measured differently than its book value, which is the value of Axsome that is recorded on the company's balance sheet. Investors also form their own opinion of Axsome Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Axsome Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axsome Therapeutics' market value can be influenced by many factors that don't directly affect Axsome Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axsome Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Axsome Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axsome Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.